ReviewMedComm2026

Osimertinib Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Mechanisms and Therapeutic Strategies.

Junfeng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.